Kennedy Paul F. 4
4 · IVAX DIAGNOSTICS INC · Filed Sep 1, 2010
Insider Transaction Report
Form 4
Debregeas Patrice
Director10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2010-09-01$0.75/sh−14,350,000$10,762,500→ 0 total - Sale
Common Stock, $0.01 par value
2010-09-01$0.75/sh−26,313$19,735→ 0 total - Sale
Common Stock, $0.01 par value
2010-09-01$0.75/sh−2,800,000$2,100,000→ 0 total - Sale
Common Stock, $0.01 par value
2010-09-01$0.75/sh−2,850,000$2,137,500→ 0 total
Footnotes (6)
- [F1]On September 1, 2010, a group comprised of Debregeas & Associes Pharma SAS, Patrice R. Debregeas, Umbria LLC and Paul F. Kennedy sold to ERBA Diagnostics Mannheim GmbH (the "Purchaser"), in a privately negotiated transaction, an aggregate of 20,026,313 shares of the issuer's common stock at a purchase price of $0.75 per share (the "Transaction").
- [F2]Represents shares of the issuer's common stock sold in the Transaction which were directly owned solely by Debregeas & Associes Pharma SAS and indirectly owned by Patrice R. Debregeas, who may be deemed to control Debregeas & Associes Pharma SAS.
- [F3]Represents shares of the issuer's common stock sold in the Transaction which were directly owned solely by Patrice R. Debregeas.
- [F4]Represents shares of the issuer's common stock sold in the Transaction which were directly owned solely by Umbria LLC and indirectly owned by Paul F. Kennedy, the sole equity owner of Umbria LLC.
- [F5]Represents shares of the issuer's common stock sold in the Transaction which were directly owned solely by Paul F. Kennedy.
- [F6]In connection with the consummation of the Transaction, Patrice R. Debregeas and Paul F. Kennedy resigned as directors of the issuer, effective immediately.